 |
|
|
| |
Boceprevir/Telaprevir-Based Therapy in HIV-Infection: Interim Analysis of a Multicenter Cohort
|
| |
| |
Reported by Jules Levin
CROI 2014 March 3-6 Boston, MA
Karin Neukam1,2, Daniela I Munteanu3,4, Antonio Rivero5, Annette Haberl6, Manuel Marquez7, Patrick Ingiliz8, Ignacio de los Santos-Gil9, Thomas Lutz10, Jurgen K Rockstroh3,4, Juan A Pineda1,2
1Valme University Hospital, Seville, Spain. 2Seville Institute of Biomedicine (IBiS), Seville, Spain; 3Bonn University Hospital, Bonn, Germany; 4Matei Bals National Institute of Infectious Diseases, Bucharest, Romania; 5Reina Sofia University Hospital, Cordoba, Spain; 6Frankfurt University Hospital, Frankfurt/Main, Germany; 7Virgen de la Victoria University Hospital, Malaga, Spain; 8Medical Center for Infectious Diseases, Berlin, Germany; 9La Princesa University Hospital, Madrid, Spain; 10Infektiologikum, Frankfurt am Main, Germany.
|
| |
|
|
|
|
|
